M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Retained Earnings Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Retained Earnings
-$116.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Retained Earnings
-$1.3B
CAGR 3-Years
-27%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Retained Earnings
-CHf354.6m
CAGR 3-Years
-29%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Retained Earnings
-$1.3B
CAGR 3-Years
-190%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Retained Earnings
-CHf214.6m
CAGR 3-Years
1%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Retained Earnings
CHf262.6m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Retained Earnings?
Retained Earnings
-116.7m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Retained Earnings amounts to -116.7m USD.

What is MoonLake Immunotherapeutics's Retained Earnings growth rate?
Retained Earnings CAGR 1Y
-45%

Over the last year, the Retained Earnings growth was -45%.

Back to Top